CavirTM
Entecavir
Hepatitis Antivirals (Systemic Antiviral)
Indication:
CavirTM is indicated for the treatment of chronic hepatitis B virus infection in adults
with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
Dosage & Administration:
CavirTM should be administered on an empty stomach (at least 2 hours after a meal or 2 hours before the next meal).
Nucleoside-treatment-naive (16 years): 0.5 mg once daily.
Lamivudine-refractory or known lamivudine or Telbivudine resistance mutations (16 years): 1 mg once daily.
Preparation:
CavirTM 0.5 Tablet: Each box contains 10 tablets in Alu-Alu blister pack.
CavirTM 1 Tablet: Each box contains 10 tablets in Alu-Alu blister pack.
